Chitosan is a chitin derivative which is a long chain polymer abundantly found in aquatic animals including shrimps, crabs, prawn and lobsters. Shrimps are the major source of chitosan with chitin content of over 25% to 40%. Chitosan act as a good flocculant owing to its properties such as high deposition rate and efficient removal of organic matter and suspended solids. Depleting natural water reserves supported by rapid increase in population has led to growth in water treatment activities, thus stimulating industry growth.
Recent innovations in pharmaceutical market has led to the development for chitosan nano particles which helps in drug delivery to specific target site, thus acting as a one way drug release for COVID 19 drug in lungs of affected patients. It will help in generating intra pulmonary drug delivery formulation suitable for treating COVID 19, thus promoting industry growth in this sector. However, certain production closures, lockdown, insufficient availability of resources might have effect on product commercialization which is likely to act as restricting factor.
The report provides market estimation & forecast for global chitosan market considering economic conditions during COVID 19 pandemic. Study impact of COVID 19 on market value with holistic approach considering both supply and demand side of the market. Macro and Micro economic factors analysis pertaining to economic policies, GDP and international trade changed due to COVID 19. After COVID 19 scenarios with coping strategies adopted by the major market players
The global market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World. North America comprises of U.S., Canada and Mexico. Whereas, Europe covers UK, France, Germany, Italy, Spain and Rest of Europe. The key countries included under Asia Pacific are China, India, Japan and Rest of Asia Pacific. The Rest of the world includes Latin America and Middle East & Africa.
Asia Pacific is a lucrative region and dominated chitosan market in 2019. Asia Pacific led by India, Japan and China is projected to continue its dominance in the foreseeable timeframe. Japan is a major producer of chitosan owing to high and easy availability of raw material will drive regional industry growth. In, addition favourable regulatory norms regarding FDA approvals of chitosan derivatives in dietary products will further propel product demand in this region.
The key players in the chitosan market share are Primex EHF, Heppe Medical Chitosan GmbH, Vietnam Food, Kitozyme S.A., Agratech, Advanced Biopolymers as, Bio21 Co., Ltd., G .T.C. Bio Corporation, Taizhou City Fengrun Biochemical Co., Ltd., Zhejiang Golden-Shell Pharmaceutical Co., Ltd., Ningbo Zhenhai Haixin Biological Products Co. Ltd., Weifang Haizhiyuan Biological Products Co., Ltd., Qingdao Yunzhou Biochemistry Co., Ltd, Panvo Organics Pvt Ltd, Xianju Tengwang Chitosan Factory, PT Biotech Surindo, Koyo Chemical Co., Ltd. New product development, acquisition, collaborations and partnerships remains the key business strategies to enhance product offering.
The report analyses the global chitosan market based on source, grade, application and geography. Various source studied are segmented into shrimps, prawns, crabs, lobsters. Various chitosan grades studied are pharmaceutical, food, industrial. Furthermore, the major application considered in the study is food & beverage, water treatment, cosmetics, pharmaceutical, agrochemicals, biotechnology
The global market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World. North America comprises of U.S., Canada and Mexico. Whereas, Europe covers UK, France, Germany, Italy, Spain and Rest of Europe. The key countries included under Asia Pacific are China, India, Japan and Rest of Asia Pacific. The Rest of the world include Latin America and Middle East & Africa.
Why to buy this report: